Veritas Farms, Inc. (OTCPK: VFRM)
Health Care · Pharmaceuticals · US
$0.00
— today · 0.0% 1Y
Veritas Farms, Inc. (OTCPK: VFRM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.30K and employs 17 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.10.
Tweenvest scores Veritas Farms, Inc. across four factors: quality 12/100, value 46/100, growth 0/100. Its strongest factor is value.
VFRM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.30K
- Revenue (TTM)
- $883.65K
- P/E
- —
- EPS
- -0.11
- Dividend yield
- —
- Beta (5Y)
- 0.55
- 52-week high
- $0.10
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 162.95M
- Employees
- 17
- Next earnings
- —
About Veritas Farms, Inc.
Veritas Farms, Inc. focuses on growing, producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company’s products include capsules, gummies, tinctures, lotions, salves, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through bulk, white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Fort Lauderdale, Florida.
- ISIN
- US92347N2071
- Listed since
- Jun 16, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.61 | +0.10% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.78 | +0.57% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.20 | -0.23% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.90 | -1.52% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.80 | -1.31% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.